<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Olopatadine (ophthalmic): Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Olopatadine (ophthalmic): Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Olopatadine (ophthalmic): Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="9894" href="/d/html/9894.html" rel="external">see "Olopatadine (ophthalmic): Drug information"</a> and <a class="drug drug_patient" data-topicid="12274" href="/d/html/12274.html" rel="external">see "Olopatadine (ophthalmic): Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F9502830"><span class="drugH1">Brand Names: US</span>
<ul>
<li>FT Eye Allergy Itch &amp; Redness [OTC];</li>
<li>FT Eye Allergy Itch Relief [OTC];</li>
<li>Pataday [OTC];</li>
<li>Patanol [DSC];</li>
<li>Pazeo [DSC]</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52869744"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>ACT Olopatadine [DSC];</li>
<li>APO-Olopatadine;</li>
<li>JAMP-Olopatadine;</li>
<li>MINT-Olopatadine;</li>
<li>Pataday;</li>
<li>Patanol;</li>
<li>Pazeo;</li>
<li>SANDOZ Olopatadine</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F11164273"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Histamine H<sub>1</sub> Antagonist</span>;</li>
<li>
<span class="list-set-name">Histamine H<sub>1</sub> Antagonist, Second Generation</span></li></ul></div>
<div class="block dop drugH1Div" id="F9502959"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c660d35e-4b6b-47f5-97c4-03b280285a2f">Allergic conjunctivitis/ocular itching</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Allergic conjunctivitis/ocular itching:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Olopatadine 0.1%: Children ≥2 years and Adolescents: Ophthalmic: Instill 1 drop into affected eye(s) twice daily, allowing 6 to 8 hours between doses.</p>
<p style="text-indent:-2em;margin-left:4em;">Olopatadine 0.2%: Children ≥2 years and Adolescents: Ophthalmic: Instill 1 drop into affected eye(s) once daily.</p>
<p style="text-indent:-2em;margin-left:4em;">Olopatadine 0.7%: Children ≥2 years and Adolescents: Ophthalmic: Instill 1 drop into affected eye(s) once daily.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51131700"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block dohp drugH1Div" id="F51131701"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block doa drugH1Div" id="F9502960"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="9894" href="/d/html/9894.html" rel="external">see "Olopatadine (ophthalmic): Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="092bff5f-8753-4a3f-bbbc-5e002bc2398d">Allergic conjunctivitis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Allergic conjunctivitis:</b>
<b>Ophthalmic:</b></p>
<p style="text-indent:-2em;margin-left:4em;">0.1%: Instill 1 drop into each affected eye twice daily (allowing 6 to 8 hours between doses).</p>
<p style="text-indent:-2em;margin-left:4em;">0.2%: Instill 1 drop into each affected eye once daily.</p>
<p style="text-indent:-2em;margin-left:4em;">0.7%: Instill 1 drop into each affected eye once daily.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990719"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block doha drugH1Div" id="F50988071"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block adr drugH1Div" id="F9502892"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Central nervous system: Headache (≤5%)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gastrointestinal: Dysgeusia (2% to 5%), nausea (≤5%)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Infection: Cold symptoms (≤10%)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Neuromuscular &amp; skeletal: Back pain (≤5%), weakness (≤5%)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Ocular: Abnormal sensation in eyes (2% to 5%), blurred vision (2% to 5%), dry eye syndrome (2% to 5%), superficial punctate keratitis (2% to 5%), burning sensation of eyes (≤5%), conjunctivitis (≤5%), eyelid edema (≤5%), eye pain (≤5%), eye pruritus (≤5%), foreign body sensation (≤5%), keratitis (≤5%), stinging of eyes (≤5%), hyperemia</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Respiratory: Pharyngitis (≤10%), cough (≤5%), rhinitis (≤5%), sinusitis (≤5%)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Miscellaneous: Flu-like symptoms (≤5%), hypersensitivity (≤5%), infection (≤5%)</p></div>
<div class="block coi drugH1Div" id="F9502889"><span class="drugH1">Contraindications</span>
<p style="text-indent:-2em;margin-left:2em;">Hypersensitivity to olopatadine hydrochloride or any component of the formulation.</p>
<p style="text-indent:-2em;margin-left:2em;">OTC labeling (Pataday): When used for self-medication, do not use if hypersensitive to olopatadine hydrochloride or any component of the formulation, or to treat contact lens-related irritation.</p></div>
<div class="block war drugH1Div" id="F9502890"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Contact lens: Not for use to treat contact lens-related irritation. Solution contains benzalkonium chloride; remove lens prior to administration and wait ≥10 minutes before reinserting. Do not use contact lenses if eyes are red.</p>
<p style="text-indent:-2em;margin-left:4em;">• Self-medication (OTC use): Discontinue use and contact health care provider if eye pain or changes in vision occur, redness or irritation of the eye continues, or condition worsens or persists for &gt;3 days. Do not use if solution changes color or becomes cloudy.</p></div>
<div class="block foc drugH1Div" id="F9504109"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Ophthalmic: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">FT Eye Allergy Itch &amp; Redness: 0.1% (5 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">FT Eye Allergy Itch Relief: 0.2% (2.5 mL) [contains benzalkonium chloride, edetate (edta) disodium]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Pataday: 0.1% (5 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Pataday: 0.2% (2.5 mL) [contains benzalkonium chloride, edetate (edta) disodium]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Pataday: 0.7% (2.5 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Patanol: 0.1% (5 mL [DSC]) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Pazeo: 0.7% (2.5 mL [DSC]) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.1% (5 mL); 0.2% (2.5 mL)</p></div>
<div class="block geq drugH1Div" id="F9502833"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F9504111"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Olopatadine HCl Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1% (per mL): $1.82 - $3.65</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.2% (per mL): $4.22 - $71.76</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Pataday Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1% (per mL): $2.98</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.2% (per mL): $5.71</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.7% (per mL): $5.76</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52869745"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Ophthalmic: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Pataday: 0.2% (0.5 mL, 2.5 mL) [contains benzalkonium chloride, edetate (edta) disodium]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Patanol: 0.1% (5 mL, 10 mL, 15 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Pazeo: 0.7% (2.5 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.1% (1 mL, 5 mL, 10 mL, 15 mL); 0.2% (2.5 mL)</p></div>
<div class="block admp drugH1Div" id="F52614392"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Ophthalmic: For topical ophthalmic use only; not for injection or oral use. Wash hands prior to use. Do not touch tip of container to eye, eyelid, or other surfaces. After instilling drops, wait ≥10 minutes before inserting contact lenses (contains benzalkonium chloride). Do not insert contacts if eyes are red. If using other eye drops/ointments, wait ≥5 minutes before or after administering other eye drops.</p></div>
<div class="block adm drugH1Div" id="F9503432"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Ophthalmic:</b> For topical ophthalmic use only. Wash hands prior to use. Do not touch tip of container to eye. After instilling drops, wait ≥10 minutes before inserting contact lenses. Do not insert contacts if eyes are red. If using other eye drops, wait at least 5 minutes before administering other eye drops.</p></div>
<div class="block sts drugH1Div" id="F9502940"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;">OTC 0.2% and 0.7%: Store at 2°C to 25°C (36°F to 77°F).</p>
<p style="text-indent:0em;">OTC 0.1% and Rx products: Store at 4°C to 25°C (39°F to 77°F).</p></div>
<div class="block usep drugH1Div" id="F53570713"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Temporary relief of eye itching and redness due to pollen, ragweed, grass, animal hair and dander, or allergic conjunctivitis (FDA approved in ages ≥2 years and adults).</p></div>
<div class="block mst drugH1Div" id="F9502742"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Patanol may be confused with Platinol</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">International issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Patanol [US, Canada, and multiple international markets] may be confused with Bétanol brand name for metipranolol [Monaco] </p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13299786"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F9502897"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F9502887"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline">Olopatadine has minimal systemic absorption following ophthalmic administration. Systemic absorption would be required in order for olopatadine to cross the placenta and reach the fetus.</p></div>
<div class="block pha drugH1Div" id="F9502941"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Selective histamine H<sub>1</sub>-antagonist; inhibits release of histamine from mast cells. Inhibits histamine induced effects on conjunctival epithelial cells.</p></div>
<div class="block phk drugH1Div" id="F9502943"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Low systemic absorption (Patanol prescribing information 2018).</p>
<p style="text-indent:-2em;margin-left:2em;">Half-life elimination: ~3 hours (Meier 2017; Patanol prescribing Information 2018).</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Urine (60% to 70%, mostly as unchanged drug) (Patanol prescribing Information 2018).</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F10961997"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Olopat | Pataday | Patanol</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Keim aler | Olopat f | Oloratan | Patanol | Pazeo | Timalerg | Zepiken | Zoloatlas</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Olopatadin unimed pharma</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Apo olopatadine | Paladopt | Patanol</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Alacot | Alacot max | Aladay | Alchek | Alercon | Alleloc ds | Allet | Contova | Lopadine max | Olarif | Olodin | Ologen max | Olopan | Olopan pro | Opatin | Patadin | Patadin max | Patalon | Patanol</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Opatanol</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Alerchek</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Olopatadine unimed pharma | Olovision | Opatanol</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Clor olopatadina | Cloridrato de olopatadina | Holli | Lodina | Patanol | Patanol s | Visodina</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Allercheck</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Alergiol forte | Olodina | Olof | Patanol | Patanol s | Zepiken</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Patanol</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Alap | Alercare | Alercare plus | Alernit | Atapol | Expotadina | Oftalmotrialer | Oftipat | Olodina | Olodina pf | Olodinex | Oloftal | Oloftal pf | Oloftal ud | Olopadex | Olopat | Olopatadina | Olopharm | Olopharm o | Olvision | Olvision s | Optyline | Pataler | Patanol | Patanol s | Pazeo | Sinnaleroft</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Alerpalux | Ofnol | Olopatadine unimed pharma | Opatanol</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Olopatadin micro labs | Opatanol</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Alergalop | Fermal | Hapatox | Kuara | Oftadina | Olof | Patadine Plus | Patanol | Patanol s</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Alap | Alerfin | Alergiol forte | Alergiol forte nf | Alergiol nf | Olof | Patanol | Patanol s</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Olopatadine unimed pharma | Opatanol</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Conjyclear | Olohistine | Olomansys | Olopat | Olopatanol | Patanergic | Patanol</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Apadin | Olopatadina abamed | Opatanol</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Alercon | Olodin | Olopan | Olopat | Patanol | Rapidon</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Opatanol</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Opatanol</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Olopatadine | Opatanol</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Alopatan | Opatanol</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Paradin | Pataday | Patanol</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">Opatanol</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Opatanol</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Lergio</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Opatanol</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Alerchek | Arest | Bell patadine | If1 | If2 | Lopine | Nayanpat | Neolap | Odin | Olasial | Olaz od | Olo | Olo 1 | Olobet | Oloblu | Oloday | Olomed | Olopat max | Olopine | Oloplus | Olotak | Olotop | Olozi | Olways | Optihist pat | Pataday | Patalo | Patanol | Patdrop ds | Patif | Petolo | Polo | Rapidon | Winolap</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Opatanol</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Conjyclear | Olopat | Patanol</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Olopatadine | Olopatadine kyorin | Olopatadine nissin | Olopatadine nitten | Olopatadine nitto | Olopatadine sandoz | Olopatadine sawai | Olopatadine towa | Olopatadine ts | Olopatadine wakamoto | Patanol</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Alacot ds | Aladay | Aladay ds | Alerchek | Lopadine | Neolap | Olopat | Olopat od | Optihist pat | Patanol | Winolap | Winolap ds</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Alinol | Alleless | Allenol | Allenold | Allepatadine | Allervid | Alpaday Ophthalmic Solution 0.2% | Alpadin | Alphaday | Bearnol | Cleaday | Dailyonce | Exol | Eye padine | Eyepatadin | Huons olopatadine hcl | I olo | I padine | Litaday | Lite olon | Lopadine | Luce p | Oculadine | Ocuolo | Oleone | Olo I | Olo once | Olobella | Olobella sd | Olobid M | Oloeye | Olopa | Olopadine | Olopanol | Oloscar | Olotadine | Oloten | Oloten plus | Olpaday | Olpadin | Olpadine | Oltadine | Opadine | Optipadin | Paradine | Pataday | Patadin q | Patadine | Pataeyen | Patanol | Pataol | Pataonce | Pazeo | Ritanol | Tapadine | Unipadine | Vitanol</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Olopat | Pataday | Patanol</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Allervid | Conjyclear | Olopat | Pataday | Patanol</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Alerpalux | Olopatadine unimed pharma | Opatanol</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Opatanol</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Alerpalux | Olopatadine unimed pharma | Opatanol</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Opatanol</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Imbalza | Olofcon | Olopatadina | Patanol | Provigenol | Sunolap | Ulopat</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Olodin | Olopan | Pataday | Patanol</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">Alerchek | Katanol | Norotadin | Olopat | Olpadin | Opatanol | Rapidon eye drops | Vispadin</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Opatanol</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Opatanol | Patanol | Toredin</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Olopatadine | Patanol</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Alergipat | Alergoftal | Lergitin | Melius | Olof | Patanol | Patanol s | Winolap ds</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Olotop | Patanol</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Eyepat | Liper | Ocudine | Ogate | Ogate forte | Oloblu | Olomine ds | Olopat | Olopharm forte | Olopine | Oloptik | Oloptik forte | Olosaf | Olosir ds | Olotek | Olotek ds | Opat | Opat forte | Opdine | Optidine | Otadine | Pataday | Patadin | Patanol | Patlerg forte | Plop forte | Raypat | Valopat | Valopat ds | Winolap | Xepat | Zolopat</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Alerpalux | Nolodon | Oftahist | Olodon Free | Opatanol | Starazolin alergia | Starelltec Alergia</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Olopatadine | Olopatadine HCL | Pataday | Patanol | Pazeo</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Opatanol</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Alergiol forte nf | Alergiol nf | Mastobloc | Oftalmol aler | Olof | Patanol | Patanol s | Zoloatlas</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Olopat | Pataday | Patanol</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Olopatadina | Olopatadina unimed pharma | Opatanol</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Oloftadin eco | Olopatallerg | Oloridin | Visallergol</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Olopat | Pataday | Patanol</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Olopatadin orifarm | Opatanol | Toredin</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Pataday | Patanol | Pazeo</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Olopatadin unimed pharma | Opatanol</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Alerpalux | Olopatadine unimed pharma | Opatanol</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Olo a day | Olopa mac | Patanol</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Olopan | Opatanol</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Dupatin | Ofnol | Ofnol s | Oladin | Pallada | Patanol</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Olopan | Patanol</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Olopatadine | Pallada | Vizallergol</span>;</li>
<li>
<span class="countryCode">(UG)</span> <span class="country">Uganda</span><span class="countrySeparator">: </span><span class="drugName">Alacot | Alerchek | Olohistine | Olopat</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Criptinal | Kuara | Olopatadina | Patanol</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Alap | Alerpat | Kuara | Olocof | Olopatadina | Opat | Patanol | Patanol s</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Patanol</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Neolap</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Patanol</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-28435218">
<a name="28435218"></a>Meier E, Narvekar A, Iyer GR, et al. Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies. <i>Clin Ophthalmol</i>. 2017;11:669-681. doi:10.2147/OPTH.S126690<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/olopatadine-ophthalmic-pediatric-drug-information/abstract-text/28435218/pubmed" id="28435218" target="_blank">28435218</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Olopatadine hydrochloride ophthalmic solution, 0.1% [prescribing information]. Mendham, NJ: Somerset Therapeutics, LLC; June 2016.</div>
</li>
<li>
<div class="reference">
                  Olopatadine hydrochloride ophthalmic solution, 0.1% [prescribing information]. Morgantown, WV: Mylan; July 2017.</div>
</li>
<li>
<div class="reference">
                  Olopatadine hydrochloride ophthalmic solution, 0.2% [prescribing information]. Lake Forest, IL: Akorn; December 2017.</div>
</li>
<li>
<div class="reference">
                  Pataday 0.1% Twice a Day Relief (olopatadine hydrochloride) [prescribing information]. Fort Worth, TX: Alcon; November 2021.</div>
</li>
<li>
<div class="reference">
                  Pataday 0.2% Once Daily Relief (olopatadine hydrochloride) [prescribing information]. Fort Worth, TX: Alcon; April 2021.</div>
</li>
<li>
<div class="reference">
                  Pataday 0.7% Once Daily Relief (olopatadine hydrochloride) [prescribing information]. Fort Worth, TX: Alcon; April 2021.</div>
</li>
<li>
<div class="reference">
                  Patanol (olopatadine hydrochloride) [prescribing information]. Fort Worth, TX: Alcon; April 2018.</div>
</li></ol></div><div id="topicVersionRevision">Topic 127601 Version 174.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
